This is a few days old now, unless you subscribe access to up to date info is limited, and our benchmark is 44%, not 37%, but the relationship between the price we receive after grade discount and 37% gif Tianjin is fairly close as well.
For completeness I have included the PFS chart below as well.
Prices are broadly similar to where they were when the PFS was done. 44% above US$5, 37% mid us$4,s
Anything else being posted about other benchmarks or market movements is rubbish!
Justin confirmed last week that prices were around to marginally higher than PFS.
44% MN was at US$5.14 for the first shipment and US$5.35 for the second shipment or thereabouts. Can't obviously be precise about that.
We don't know what FOB conversion is. We don't know if we are receiving mineral credits yet. If I remember correctly credits were only applied to 85% of total volume so maybe its something that kicks in over time.
Regardless, US$5.25 average, 15% discount for grade, increase FOB conversion 30% from December and no mineral credits .....US$4 /dmtu
If we are getting mineral credits, US$4.65. Personally I think it may be too early for those so I would be expecting the former for the first few shipments.
PFS operating costs starting at Stage 1 of US$2.91 dropping to US$2.65. We have already taken cost hits in FOB conversion above.
Regardless of what some mis-guided individuals are posting, that's the state of things at the moment.
The next step is already funded. There is still plenty of profit to be made as a stand alone ore business at current levels. Like any commodity market there will be fluctuations, but the PFS was appropriately conservative. In a couple of years, we hope most of this will be largely irrelevant because we will need most of the product for HPMSM.
- Forums
- ASX - By Stock
- Ann: Element 25 Granted Patent for High Purity Manganese Process
E25
element 25 limited
Add to My Watchlist
0.00%
!
22.5¢

This is a few days old now, unless you subscribe access to up to...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.43M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.5¢ | $21.94K | 100.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 62609 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 0.215 |
2 | 5119 | 0.210 |
2 | 8107 | 0.205 |
7 | 59405 | 0.200 |
3 | 13077 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 62609 | 2 |
0.230 | 72958 | 1 |
0.235 | 24800 | 2 |
0.240 | 252084 | 2 |
0.245 | 21276 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online